4.7 Article

Heat shock preconditioning mesenchymal stem cells attenuate acute lung injury via reducing NLRP3 inflammasome activation in macrophages

Journal

STEM CELL RESEARCH & THERAPY
Volume 12, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13287-021-02328-3

Keywords

Heat shock; Umbilical cord-derived mesenchymal stem cells; Acute lung injury; Macrophage; NLRP3 inflammasome

Funding

  1. National key research and development program [2017YFA0104304]
  2. National Natural Science Foundation of China [81570593, 81670601, 81770648, 81802402, 81870449, 81901943, 81900597, 31701116]
  3. Guangdong Natural Science Foundation [2015A030312013, 2018A030310323, 2018A030310275, 2021A1515012382]
  4. Sci-tech Research Development Program of Guangdong province [2017A020215023]
  5. Medical Scientific Research Foundation of Guangdong Province [A2018130]
  6. Sci-tech Research Development Program of Guangzhou city [158100076]
  7. Young Teacher Development Program of Sun Yat-Sen University [17ykpy57, 20ykpy33]
  8. China Postdoctoral Science Foundation [2019 M653199]
  9. Fundamental Research Funds for the Sun Yat-sen Universities [18zxxt08]

Ask authors/readers for more resources

This study demonstrated that heat shock pretreatment can enhance the beneficial effects of umbilical cord-derived mesenchymal stem cells in inhibiting NLRP3 inflammasome activation in macrophages during acute lung injury, possibly related to the upregulated expression of HSP70.
Objectives: Acute lung injury (ALI) remains a common cause of morbidity and mortality worldwide, and to date, there is no effective treatment for ALI. Previous studies have revealed that topical administration of mesenchymal stem cells (MSCs) can attenuate the pathological changes in experimental acute lung injury. Heat shock (HS) pretreatment has been identified as a method to enhance the survival and function of cells. The present study aimed to assess whether HS-pretreated MSCs could enhance immunomodulation and recovery from ALI. Materials and methods: HS pretreatment was performed at 42 degrees C for 1 h, and changes in biological characteristics and secretion functions were detected. In an in vivo mouse model of ALI, we intranasally administered pretreated umbilical cord-derived MSCs (UC-MSCs), confirmed their therapeutic effects, and detected the phenotypes of the macrophages in bronchoalveolar lavage fluid (BALF). To elucidate the underlying mechanisms, we cocultured pretreated UC-MSCs with macrophages in vitro, and the expression levels of inflammasome-related proteins in the macrophages were assessed. Results: The data showed that UC-MSCs did not exhibit significant changes in viability or biological characteristics after HS pretreatment The administration of HS-pretreated UC-MSCs to the ALI model improved the pathological changes and lung damage-related indexes, reduced the proinflammatory cytokine levels, and modulated the M1/ M2 macrophage balance. Mechanistically, both the in vivo and in vitro studies demonstrated that HS pretreatment enhanced the protein level of HSP70 in UC-MSCs, which negatively modulated NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in alveolar macrophages. These effects were partially reversed by knocking down HSP70 expression. Conclusion: HS pretreatment can enhance the beneficial effects of UC-MSCs in inhibiting NLRP3 inflammasome activation in macrophages during ALI. The mechanism may be related to the upregulated expression of HSP70.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available